FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
NXP / 10NAD+ 1000MG NexPep research vial

Research profile

NAD+

1000MG

Cellular redox cofactor research material

Nicotinamide adenine dinucleotide (NAD+) is a central redox cofactor used throughout cellular metabolism. It cycles between oxidised NAD+ and reduced NADH forms to transfer electrons and also serves as a substrate for enzymes including sirtuins and PARPs.

CLASSComplexesFORMATLyophilised research materialEVIDENCEHigher-fill presentation · established biochemistry with context-dependent intervention outcomes
View collectionRequest documentation

Scientific context

What it does.

NAD+ research examines energy metabolism, mitochondrial function, redox balance, DNA-repair signalling and NAD-consuming enzyme activity. Direct NAD+ and NAD-precursor experiments are not interchangeable; transport, metabolism and compartmentalisation can produce different results.

Mechanism map

How the research
model works.

01

Redox transfer

NAD+/NADH couples oxidation and reduction reactions across glycolysis, the citric-acid cycle and oxidative phosphorylation.

02

Enzyme substrate

NAD+ is consumed by signalling and repair enzymes including sirtuins, PARPs and CD38-linked pathways.

03

Compartment control

Cytosolic, nuclear and mitochondrial NAD pools are regulated differently, making sampling location and timing critical.

Study design

Research pairing
options.

These are experimental design concepts—not recommendations for human use, co-administration or dosing.

PAIR / 01

Retatrutide

Supports factorial metabolic studies connecting receptor-level signalling with cellular redox and energy endpoints.

Use separate and combined arms; this is a study-design concept, not a human-use recommendation.
PAIR / 02

GHK-CU 50MG

Adds a defined matrix-remodelling axis to oxidative-stress or cellular-repair models.

Copper-dependent redox chemistry may alter assays, so include interference controls.
PAIR / 03

Wolverine 10MG

May be used in preclinical designs connecting cellular energetics with repair-pathway readouts.

Evidence bases differ substantially; maintain single-agent controls.

Interpretation controls

Important
limitations.

Evidence trail

Primary reading.

01NAD+ and nucleotide-metabolism study02Human NAD-booster comparison03Nicotinamide-riboside human study